Dermisonics - vorbörsliche News ! - 500 Beiträge pro Seite
eröffnet am 26.04.06 15:13:50 von
neuester Beitrag 26.04.06 16:12:52 von
neuester Beitrag 26.04.06 16:12:52 von
Beiträge: 2
ID: 1.056.250
ID: 1.056.250
Aufrufe heute: 0
Gesamt: 1.311
Gesamt: 1.311
Aktive User: 0
ISIN: US24983U1043 · WKN: A0DK4Y · Symbol: DMSI
0,0000
USD
+2.400,00 %
+0,0000 USD
Letzter Kurs 19.04.24 Nasdaq OTC
Werte aus der Branche Sonstige Technologie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,1900 | +12,26 | |
27,83 | +7,45 | |
5,0600 | +6,75 | |
15,450 | +6,48 | |
15,570 | +5,85 |
Wertpapier | Kurs | Perf. % |
---|---|---|
6,0500 | -14,18 | |
10,440 | -23,40 | |
2,3600 | -27,61 | |
1,1100 | -28,39 | |
1,1540 | -61,16 |
Press Release Source: Dermisonics, Inc.
Dermisonics, Inc. Prepares U-Strip(TM) Ultrasonic Transducer Device for Mass Production
Wednesday April 26, 8:30 am ET
IRVINE, Calif., April 26 /PRNewswire-FirstCall/ -- Dermisonics, Inc. (OTC Bulletin Board: DMSI.OB - News), a medical device company focused on the development of painless, needle-free drug-delivery technology, has completed a demonstration of a mass production system for ultrasonic transducers used in its U-Strip ultrasonic drug delivery technology.
The U-Strip patented electronic system uses a specialized form of ultrasound waves to enhance the delivery of drugs through the skin and into the bloodstream from a specially modified patch. Ultrasound is generated via transducers, which convert electronic signals into mechanical energy. The transducers used in the U-Strip design emit an alternating ultrasonic waveform, sawtooth to squarewave, as opposed to ordinary transducers, which emit only sine waves, and generate a tremendous amount of heat energy as a result. The alternating signal reduces the heating effect, which could damage a drug in a transdermal patch delivery system.
Until recently these transducers were hand made to exacting specifications. Dermisonics engineers have produced a manufacturing mold system, which can fabricate the Redding Generation-5 transducers, on an assembly line basis. This step is expected to dramatically improve transducer precision and anticipated to reduce manufacturing costs.
Inventor of Dermisonics' technology and Executive VP, Bruce Redding states, "The mass production process for the Redding Generation-5 transducers significantly improves our cost structure on what is the most expensive component of the U-strip System and puts the system in a range more suitable for both our consumer products and our drug delivery applications." Redding adds. "In order to enable the wide adoption of our technology, it will be necessary to prepare for the mass production of its components. Production capability of the U-Strip transducer devices is now in place."
Dermisonics is currently recruiting recipients to proceed with a planned Human Pilot Trial-2 on its U-Strip(TM) delivery system for use with insulin on Type-2 adult diabetics.
Dermisonics, Inc. Prepares U-Strip(TM) Ultrasonic Transducer Device for Mass Production
Wednesday April 26, 8:30 am ET
IRVINE, Calif., April 26 /PRNewswire-FirstCall/ -- Dermisonics, Inc. (OTC Bulletin Board: DMSI.OB - News), a medical device company focused on the development of painless, needle-free drug-delivery technology, has completed a demonstration of a mass production system for ultrasonic transducers used in its U-Strip ultrasonic drug delivery technology.
The U-Strip patented electronic system uses a specialized form of ultrasound waves to enhance the delivery of drugs through the skin and into the bloodstream from a specially modified patch. Ultrasound is generated via transducers, which convert electronic signals into mechanical energy. The transducers used in the U-Strip design emit an alternating ultrasonic waveform, sawtooth to squarewave, as opposed to ordinary transducers, which emit only sine waves, and generate a tremendous amount of heat energy as a result. The alternating signal reduces the heating effect, which could damage a drug in a transdermal patch delivery system.
Until recently these transducers were hand made to exacting specifications. Dermisonics engineers have produced a manufacturing mold system, which can fabricate the Redding Generation-5 transducers, on an assembly line basis. This step is expected to dramatically improve transducer precision and anticipated to reduce manufacturing costs.
Inventor of Dermisonics' technology and Executive VP, Bruce Redding states, "The mass production process for the Redding Generation-5 transducers significantly improves our cost structure on what is the most expensive component of the U-strip System and puts the system in a range more suitable for both our consumer products and our drug delivery applications." Redding adds. "In order to enable the wide adoption of our technology, it will be necessary to prepare for the mass production of its components. Production capability of the U-Strip transducer devices is now in place."
Dermisonics is currently recruiting recipients to proceed with a planned Human Pilot Trial-2 on its U-Strip(TM) delivery system for use with insulin on Type-2 adult diabetics.
Antwort auf Beitrag Nr.: 21.329.534 von LuckyLunatic am 26.04.06 15:13:50Hallo, kannst Du mir sagen was das alles in Deutsch heißt. Danke
Beitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
Wertpapier | Perf. % |
---|---|
+0,10 | |
+1,48 | |
-0,18 | |
-0,85 | |
-1,42 | |
+0,32 | |
-2,69 | |
-1,22 | |
0,00 | |
+0,42 |
Meistdiskutiert
Wertpapier | Beiträge | |
---|---|---|
139 | ||
63 | ||
42 | ||
26 | ||
25 | ||
21 | ||
20 | ||
17 | ||
13 | ||
12 |